Notice of Intent to Sole Source Xpress, COV-2/Flu/RSV Plus and Xpress, SARS-COV-2 Plus Test Kits

Award Notice Posted May 3, 2023

Solicitation number: 36C25723D0038
Agency: Veterans Integrated Service Network 17 Veterans Health Administration, Department of Veterans Affairs
Awarded: May 2, 2023 to Cepheid
Set-aside: No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated May 3, 2023.

1. Texas Valley Costal Bend Health Care System (TXVCB) has a need for the SARS-COV-2 PLUS and COV-2/FLU/RSV PLUS test kits compatible with the Cepheid Instrumentation. The COVID19 test kits are the only approved FDA Emergency Use Authorization that is exclusively made to work on the current VCB owned Cepheid Analyzers. The SARS CoV-2 and the SARS-CoV-2/Flu/RSV test kits are a rapid, multiplexed real-time RT-PCR test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA in either nasopharyngeal swab, nasal swab or nasal wash/aspirate specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider suspected of COVID-19 by their healthcare provider, pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. §360bbb-3). The COVID and COVID/FLU/RSV is for use only under EUA in the United States (U.S.) in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests.

Awarded contract 36C25723D0038 to CEPHEID for 1400000.00 on 2023-05-02.

File	Type	Posted
C01 Award Notice.pdf	PDF	May 3, 2023

Notice	Type	Posted
This notice Award	Award Notice	May 3, 2023
Notice of Intent to Sole Source Xpress, COV-2/Flu/RSV Plus and Xpress, SARS-COV-2 Plus Test Kits Latest special notice	Special Notice	Dec 20, 2022

On GovTribe

Try for free Login